Penumbra Inc (PEN) Stock Price, Quote & News

Company Profile

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under...

Industry: Medical Devices

Sector: Healthcare

Phone: 510 748 3200

Website: www.penumbrainc.com

Address:

One Penumbra Place, Alameda, United States

StockConsultant Aug. 13 at 3:27 AM

A good day for stocks rallying off support with $AMBA $HLT ICLR $M $PEN and $SYF at https://stockconsultant.com/?AMBA

0 · Reply

scientificway Aug. 3 at 4:25 AM

$PEN check MDXG out, up run started today, excelent guidance

0 · Reply

JarvisFlow Jul. 31 at 3:38 PM

Morgan Stanley has updated their rating for Penumbra ( $PEN ) to Equal-Weight with a price target of 266.

0 · Reply

Looking4Bargain Jul. 31 at 7:40 AM

$PEN Always comes through with good earnings. Positioned for acquisition but it's a money maker.

0 · Reply

JarvisFlow Jul. 30 at 3:47 PM

Truist Securities has updated their rating for Penumbra ( $PEN ) to Buy with a price target of 310.

0 · Reply

JarvisFlow Jul. 30 at 2:54 PM

UBS updates rating for Penumbra ( $PEN ) to Buy, target set at 330 → 335.

0 · Reply

JarvisFlow Jul. 30 at 2:08 PM

Wells Fargo has updated their rating for Penumbra ( $PEN ) to Overweight with a price target of 290.

0 · Reply

JarvisFlow Jul. 30 at 12:30 PM

Canaccord Genuity has updated their rating for Penumbra ( $PEN ) to Buy with a price target of 350.

0 · Reply

OpenOutcrier Jul. 30 at 12:16 PM

$PEN (+10.1% pre) Penumbra, Inc. shares rise after-hours after Q2 earnings and revenue beat expectations. https://ooc.bz/l/71785

0 · Reply

BigSqueezeComing Jul. 30 at 11:05 AM

$PEN pm gapper

0 · Reply

Penumbra, Inc. to Present at Upcoming Investor Conferences

Aug 7, 2025, 9:45 PM EDT - 14 days ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EW EXAS GH ISRG LLY

Jul 30, 2025, 4:30 PM EDT - 23 days ago

Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 9:04 PM EDT - 23 days ago

Penumbra, Inc. (PEN) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 4:05 PM EDT - 24 days ago

Penumbra, Inc. Reports Second Quarter 2025 Financial Results

Jul 23, 2025, 9:57 AM EDT - 4 weeks ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ABT ALNY AZN EW LLY MRK

Jul 1, 2025, 4:30 PM EDT - 7 weeks ago

Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

Jun 26, 2025, 6:00 AM EDT - 2 months ago

Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner

Jun 16, 2025, 9:00 AM EDT - 2 months ago

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

Jun 5, 2025, 9:00 AM EDT - 2 months ago

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

Apr 29, 2025, 4:30 PM EDT - 4 months ago

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

Apr 29, 2025, 11:45 AM EDT - 4 months ago

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

ACLX ISRG MASI MCK NTRA TMO UNH

Apr 24, 2025, 3:27 PM EDT - 4 months ago

Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

Apr 23, 2025, 8:15 PM EDT - 4 months ago

Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 4:05 PM EDT - 4 months ago

Penumbra, Inc. Reports First Quarter 2025 Financial Results

Apr 3, 2025, 4:30 PM EDT - 5 months ago

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

Apr 2, 2025, 9:00 AM EDT - 5 months ago

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

Feb 21, 2025, 4:05 PM EST - 6 months ago

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

Feb 19, 2025, 4:03 PM EST - 6 months ago

Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook

Feb 18, 2025, 11:04 PM EST - 6 months ago

Penumbra, Inc. (PEN) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 4:05 PM EST - 6 months ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 21, 2025, 4:30 PM EST - 7 months ago

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Dec 30, 2024, 4:30 PM EST - 8 months ago

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 17, 2024, 11:03 AM EST - 8 months ago

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Nov 20, 2024, 4:30 PM EST - 9 months ago

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 5, 2024, 9:00 AM EST - 10 months ago

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

Oct 30, 2024, 11:45 PM EDT - 10 months ago

Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:05 PM EDT - 10 months ago

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

Oct 14, 2024, 9:00 AM EDT - 11 months ago

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

Oct 2, 2024, 4:30 PM EDT - 11 months ago

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

Sep 16, 2024, 3:00 AM EDT - 1 year ago

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe

Aug 27, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

Aug 21, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 19, 2024, 9:28 PM EDT - 1 year ago

Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings

Aug 13, 2024, 7:00 AM EDT - 1 year ago

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

Aug 2, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

Jul 30, 2024, 7:25 PM EDT - 1 year ago

Penumbra, Inc. (PEN) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Reports Second Quarter 2024 Financial Results

Jul 2, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

ENOV RGEN

Jun 4, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

May 23, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

May 7, 2024, 10:33 PM EDT - 1 year ago

Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

Apr 23, 2024, 9:00 AM EDT - 1 year ago

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Apr 9, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Apr 2, 2024, 11:44 PM EDT - 1 year ago

10 Companies To Watch In Q2 2024

CRM OSK TMHC

StockConsultant Aug. 13 at 3:27 AM

A good day for stocks rallying off support with $AMBA $HLT ICLR $M $PEN and $SYF at https://stockconsultant.com/?AMBA

0 · Reply

scientificway Aug. 3 at 4:25 AM

$PEN check MDXG out, up run started today, excelent guidance

0 · Reply

JarvisFlow Jul. 31 at 3:38 PM

Morgan Stanley has updated their rating for Penumbra ( $PEN ) to Equal-Weight with a price target of 266.

0 · Reply

Looking4Bargain Jul. 31 at 7:40 AM

$PEN Always comes through with good earnings. Positioned for acquisition but it's a money maker.

0 · Reply

JarvisFlow Jul. 30 at 3:47 PM

Truist Securities has updated their rating for Penumbra ( $PEN ) to Buy with a price target of 310.

0 · Reply

JarvisFlow Jul. 30 at 2:54 PM

UBS updates rating for Penumbra ( $PEN ) to Buy, target set at 330 → 335.

0 · Reply

JarvisFlow Jul. 30 at 2:08 PM

Wells Fargo has updated their rating for Penumbra ( $PEN ) to Overweight with a price target of 290.

0 · Reply

JarvisFlow Jul. 30 at 12:30 PM

Canaccord Genuity has updated their rating for Penumbra ( $PEN ) to Buy with a price target of 350.

0 · Reply

OpenOutcrier Jul. 30 at 12:16 PM

$PEN (+10.1% pre) Penumbra, Inc. shares rise after-hours after Q2 earnings and revenue beat expectations. https://ooc.bz/l/71785

0 · Reply

BigSqueezeComing Jul. 30 at 11:05 AM

$PEN pm gapper

0 · Reply

Nurse007 Jul. 29 at 8:37 PM

$PEN bought some before close 🙌

0 · Reply

Subox Jul. 29 at 8:16 PM

$PEN this is a really nice beat and raise

0 · Reply

CatCapital_ai Jul. 29 at 8:11 PM

$PEN Earnings - Q2/2025 Revenue: $339.46M ✅ vs. $327.77M est. EPS: $0.86 ✅ vs. $0.83 est. Penumbra Q2 2025 revenue up 13.4%, with strong U.S. growth. Outlook raised, targeting $1.355B-$1.370B for 2025, with continued margin and market expansion.

0 · Reply

cubie Jul. 29 at 7:58 PM

$CAKE 58s or 68s, cubie didn neither gl bc already got spy , $PPG, $PEN, $HOG , 😅🙄

1 · Reply

cubie Jul. 29 at 7:54 PM

Earnings After Bell so Place ur Bets: $SBUX $84S or $100 (102) $BKNG $5200-$5300 or $6000 $PEN $190-$200 or $260 $V $330-$335 or $365-$370 $STX $135? or 170? last cubie looked it was 90😅

1 · Reply

Estimize Jul. 29 at 3:00 PM

$PEN reports after the close, Estimize Consensus +0.05 EPS and +2.40M Revs compared to WS http://www.estimize.com/pen/fq2-2025?utm_content=

0 · Reply

Looking4Bargain Jul. 23 at 5:17 AM

$PEN this better hit $300 soon else get positioned to get bought out by JnJ for a great price. Competition is coming hard but these guys have market share. Expecting earnings to be super.

0 · Reply

Doc_G Jul. 21 at 7:08 AM

$PEN Oh my

0 · Reply

yaydeezie Jul. 11 at 2:58 PM

$PEN why is this stock dropping? 👀🙄

0 · Reply

JarvisFlow Jul. 9 at 7:17 PM

Citigroup has updated their rating for Penumbra ( $PEN ) to Neutral with a price target of 285.

0 · Reply

NVDAMillionaire Jul. 7 at 11:32 AM

$PEN Excellent article that nails exactly where PEN stands right now. So if you want to update your PEN knowledge or get acquainted with PEN, this is a must read. https://beyondspx.com/article/penumbra-cavt-innovation-fuels-growth-and-profitability-expansion-nyse-pen

0 · Reply

JarvisFlow Jun. 20 at 10:30 AM

RBC Capital updates rating for Penumbra ( $PEN ) to Outperform, target set at 232 → 285.

0 · Reply

Market Cap	9.87B
Revenue (ttm)	1.19B
Net Income (ttm)	14.01M
EPS (ttm)	N/A
PE Ratio	72.14
Forward PE	68.69
Profit Margin	1.17%
Debt to Equity Ratio	0.00

Volume	604,846
Avg Vol	449,114
Day's Range	N/A - N/A
Shares Out	39.00M
Stochastic %K	62%
Beta	0.40
Analysts	Strong Sell
Price Target	$310.88